Strong Women Making Powerful Choices

October 19, 2021
Events
1 min read

How one simple test empowered four women with the knowledge they needed to make life-saving decisions about BRCA mutations and cancer prevention for themselves and their family.

You may also like
News Featured

Sharsheret and Yodeah Educate Women About Breast Cancer

In honor of Women’s History Month, our Women’s Philanthropy division wants you to know about Federation’s efforts to improve the lives of Jewish Women everywhere. Our Women’s Impact Initiative Grants are supporting two organizations that help Jewish women understand their […]

September 27, 20241 min read

THE MOST RELEVANT GENES FOR COMMON HEREDITARY CANCERS

* CDK4: analysis is limited to chr12:g.58145429-58145431 (codon 24). EPCAM: analysis is limited to deletions that minimally encompass the 3′ end of the gene including exons 8 and/or 9. GREM1: analysis is limited to duplications that overlap the upstream regulatory region. MITF: analysis is limited to chr3:g.70014091 (including c.952G>A). MUTYH: single heterozygous pathogenic variants, likely pathogenic variants, and variants of uncertain significance are not reported. PMS2: variants of uncertain significance are not reported for exons 12-15. Analysis excludes three variants commonly observed in the pseudogene PMS2CL: c.2182_2184delinsG, c.2243_2246delAGAA and deletion of exons 13-14 (chr7:g.6015768_6018727del). POLD1: analysis is limited to chr19:g.50909713 (including c.1433G>A). POLE: analysis is limited to chr12:g.133250250 (including c.1270C>G).
DONATE